IMP
Process View
bone mineralization
The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "bone mineralization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 1.000 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.999 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.999 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.977 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.968 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.919 | Human | |
| SMAD2 | SMAD family member 2 | 0.890 | ||
| VCAN | versican | 0.857 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.850 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.819 | ||
| FSTL1 | follistatin-like 1 | 0.813 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.777 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.723 | Human | |
| IFNG | interferon, gamma | 0.721 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.709 | ||
| IL2RB | interleukin 2 receptor, beta | 0.691 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.682 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.677 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.675 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.622 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.586 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.550 | Human | |
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.543 | ||
| SMAD7 | SMAD family member 7 | 0.541 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.531 | ||
| ACVR1 | activin A receptor, type I | 0.528 | ||
| ENG | endoglin | 0.517 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.510 | Human | |
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.507 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.482 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.480 | Human | |
| GDF5 | growth differentiation factor 5 | 0.464 | Human | |
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.451 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.442 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.438 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.372 | ||
| DPT | dermatopontin | 0.338 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.336 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.300 | Human | |
| HDAC4 | histone deacetylase 4 | 0.298 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.293 | ||
| IL8 | interleukin 8 | 0.285 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.269 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.265 | ||
| BMP4 | bone morphogenetic protein 4 | 0.259 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.250 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.243 | ||
| NOG | noggin | 0.232 | ||
| IRF4 | interferon regulatory factor 4 | 0.231 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.223 | ||
| FGF21 | fibroblast growth factor 21 | 0.213 | ||
| FGF10 | fibroblast growth factor 10 | 0.203 | ||
| KDM2B | lysine (K)-specific demethylase 2B | 0.201 | ||
| IL10 | interleukin 10 | 0.199 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.194 | Human | |
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.194 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.192 | ||
| GATA2 | GATA binding protein 2 | 0.191 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.190 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.189 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.186 | Human | |
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.185 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.180 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.176 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.174 | ||
| ELN | elastin | 0.172 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.172 | Mouse | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.165 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.162 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.157 | ||
| COL11A2 | collagen, type XI, alpha 2 | 0.153 | ||
| IL1B | interleukin 1, beta | 0.150 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.148 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.148 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.138 | ||
| DMBT1 | deleted in malignant brain tumors 1 | 0.138 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.135 | ||
| EP300 | E1A binding protein p300 | 0.132 | ||
| PCGF1 | polycomb group ring finger 1 | 0.129 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.128 | Human | |
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.127 | ||
| TNF | tumor necrosis factor | 0.125 | ||
| SLAMF7 | SLAM family member 7 | 0.119 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.117 | ||
| HIC1 | hypermethylated in cancer 1 | 0.116 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.113 | Human | |
| CCL19 | chemokine (C-C motif) ligand 19 | 0.110 | Human | |
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.106 | ||
| IDE | insulin-degrading enzyme | 0.103 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.096 | ||
| BMP2 | bone morphogenetic protein 2 | 0.094 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.091 | ||
| ARRDC3 | arrestin domain containing 3 | 0.089 | ||
| RUNX1 | runt-related transcription factor 1 | 0.089 | ||
| INHBA | inhibin, beta A | 0.089 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.088 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.085 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.082 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.081 | ||
| KRT8 | keratin 8 | 0.080 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.078 | Mouse | |
| MATK | megakaryocyte-associated tyrosine kinase | 0.078 | ||
| FGF7 | fibroblast growth factor 7 | 0.076 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.075 | ||
| TCF4 | transcription factor 4 | 0.072 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.067 | ||
| ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.067 | ||
| MGP | matrix Gla protein | 0.065 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.064 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.063 | Human | |
| TNXB | tenascin XB | 0.062 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.062 | ||
| CD2 | CD2 molecule | 0.061 | ||
| FGF3 | fibroblast growth factor 3 | 0.061 | ||
| GDNF | glial cell derived neurotrophic factor | 0.060 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.059 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.059 | ||
| KCTD1 | potassium channel tetramerisation domain containing 1 | 0.058 | ||
| SNAPIN | SNAP-associated protein | 0.056 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.053 | Human | |
| CD83 | CD83 molecule | 0.052 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.051 | Human | |
| GGA3 | golgi-associated, gamma adaptin ear containing, ARF binding protein 3 | 0.051 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.051 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.050 | ||
| IL13 | interleukin 13 | 0.050 | ||
| FOXF2 | forkhead box F2 | 0.049 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.049 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.049 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.049 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.049 | ||
| NCK2 | NCK adaptor protein 2 | 0.048 | ||
| NRP1 | neuropilin 1 | 0.048 | ||
| MMP19 | matrix metallopeptidase 19 | 0.048 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.048 | ||
| NOV | nephroblastoma overexpressed gene | 0.048 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.047 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.047 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.045 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.045 | Human | |
| TLX1 | T-cell leukemia homeobox 1 | 0.045 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.044 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.044 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.044 | ||
| IL21R | interleukin 21 receptor | 0.044 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.044 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.043 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.043 | Human | |
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.042 | ||
| PDCD1 | programmed cell death 1 | 0.042 | ||
| GPR171 | G protein-coupled receptor 171 | 0.042 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.042 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.042 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.042 | ||
| SOD3 | superoxide dismutase 3, extracellular | 0.042 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.040 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.040 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.040 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.040 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.040 | Mouse | |
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.040 | ||
| CD40LG | CD40 ligand | 0.039 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.039 | ||
| HAS2 | hyaluronan synthase 2 | 0.039 | ||
| IL1A | interleukin 1, alpha | 0.039 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.039 | ||
| IL7R | interleukin 7 receptor | 0.038 | ||
| PLA2G2D | phospholipase A2, group IID | 0.038 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.038 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.037 | ||
| PAX8 | paired box 8 | 0.036 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.036 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.036 | ||
| APP | amyloid beta (A4) precursor protein | 0.035 | ||
| SELE | selectin E | 0.035 | ||
| PRRX1 | paired related homeobox 1 | 0.035 | ||
| C3 | complement component 3 | 0.035 | ||
| UBR4 | ubiquitin protein ligase E3 component n-recognin 4 | 0.035 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.035 | ||
| FGF4 | fibroblast growth factor 4 | 0.034 | ||
| CDH10 | cadherin 10, type 2 (T2-cadherin) | 0.034 | ||
| DNAJC3 | DnaJ (Hsp40) homolog, subfamily C, member 3 | 0.034 | ||
| UBD | ubiquitin D | 0.034 | ||
| NELL1 | NEL-like 1 (chicken) | 0.034 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.034 | ||
| DCN | decorin | 0.033 | Human | |
| DARC | Duffy blood group, chemokine receptor | 0.033 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.032 | ||
| FGF18 | fibroblast growth factor 18 | 0.032 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.032 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.032 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.032 | Human | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.032 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.032 | ||
| SQSTM1 | sequestosome 1 | 0.031 | ||
| CD86 | CD86 molecule | 0.031 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.031 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.030 | ||
| FAP | fibroblast activation protein, alpha | 0.030 | ||
| NRP2 | neuropilin 2 | 0.030 | ||
| LAMA4 | laminin, alpha 4 | 0.030 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.030 | ||
| CD69 | CD69 molecule | 0.030 | ||
| DNM2 | dynamin 2 | 0.030 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.029 | ||
| MSC | musculin | 0.029 | ||
| C2 | complement component 2 | 0.029 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.029 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.029 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.028 | ||
| DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 0.028 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.028 | ||
| SULF1 | sulfatase 1 | 0.028 | ||
| FGL2 | fibrinogen-like 2 | 0.028 | ||
| CH25H | cholesterol 25-hydroxylase | 0.028 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.028 | ||
| AHR | aryl hydrocarbon receptor | 0.028 | ||
| MRC2 | mannose receptor, C type 2 | 0.028 | ||
| NEUROG2 | neurogenin 2 | 0.027 | Human | |
| JUP | junction plakoglobin | 0.027 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.027 | ||
| POU4F3 | POU class 4 homeobox 3 | 0.027 | ||
| CTGF | connective tissue growth factor | 0.027 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.027 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.026 | ||
| RUNX2 | runt-related transcription factor 2 | 0.026 | ||
| ALX4 | ALX homeobox 4 | 0.026 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.026 | ||
| PLXDC1 | plexin domain containing 1 | 0.026 | ||
| IL4 | interleukin 4 | 0.026 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.026 | Human | |
| CDX1 | caudal type homeobox 1 | 0.026 | ||
| TBX21 | T-box 21 | 0.025 | ||
| VEGFC | vascular endothelial growth factor C | 0.025 | ||
| HOXD12 | homeobox D12 | 0.025 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.025 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.025 | ||
| IL6R | interleukin 6 receptor | 0.025 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.025 | ||
| WNT10A | wingless-type MMTV integration site family, member 10A | 0.025 | Human | |
| TBX5 | T-box 5 | 0.025 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.025 | ||
| OGN | osteoglycin | 0.024 | ||
| AQP9 | aquaporin 9 | 0.024 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.024 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.024 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.024 | ||
| EFNB3 | ephrin-B3 | 0.024 | ||
| GATA4 | GATA binding protein 4 | 0.024 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.024 | ||
| EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.023 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.023 | Human | |
| BMP15 | bone morphogenetic protein 15 | 0.023 | Human | |
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.023 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.023 | ||
| ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0.023 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.023 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.023 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.023 | ||
| EGFL6 | EGF-like-domain, multiple 6 | 0.023 | ||
| FOXB1 | forkhead box B1 | 0.023 | ||
| LHX5 | LIM homeobox 5 | 0.023 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.023 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.022 | ||
| MEF2A | myocyte enhancer factor 2A | 0.022 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.022 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.022 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.022 | ||
| IL11 | interleukin 11 | 0.021 | ||
| POU4F2 | POU class 4 homeobox 2 | 0.021 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.021 | Human | |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.021 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.021 | Human | |
| SNX9 | sorting nexin 9 | 0.021 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.021 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.021 | Human | |
| STAT4 | signal transducer and activator of transcription 4 | 0.021 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.021 | ||
| ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.021 | ||
| FOXA2 | forkhead box A2 | 0.021 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.021 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.021 | Human | |
| XCL2 | chemokine (C motif) ligand 2 | 0.021 | Human | |
| SIX6 | SIX homeobox 6 | 0.020 | ||
| PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.020 | ||
| IHH | Indian hedgehog | 0.020 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.020 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.020 | ||
| CD80 | CD80 molecule | 0.020 | ||
| PSEN1 | presenilin 1 | 0.020 | ||
| HDAC9 | histone deacetylase 9 | 0.020 | ||
| FPR3 | formyl peptide receptor 3 | 0.020 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.020 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.020 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.020 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.020 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.019 | ||
| AEBP1 | AE binding protein 1 | 0.019 | ||
| DNM1 | dynamin 1 | 0.019 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.019 | ||
| MYOD1 | myogenic differentiation 1 | 0.019 | ||
| WIF1 | WNT inhibitory factor 1 | 0.019 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.019 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.019 | ||
| CD1A | CD1a molecule | 0.019 | ||
| AMHR2 | anti-Mullerian hormone receptor, type II | 0.019 | Human | |
| RSPO1 | R-spondin homolog (Xenopus laevis) | 0.019 | ||
| TBX2 | T-box 2 | 0.019 | ||
| OLFML3 | olfactomedin-like 3 | 0.019 | ||
| RARA | retinoic acid receptor, alpha | 0.019 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.019 | ||
| ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.018 | ||
| DHH | desert hedgehog | 0.018 | ||
| SMAD6 | SMAD family member 6 | 0.018 | ||
| EFS | embryonal Fyn-associated substrate | 0.018 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.018 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.018 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.018 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.018 | ||
| PAX1 | paired box 1 | 0.018 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.018 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.018 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.018 | Human | |
| CCL21 | chemokine (C-C motif) ligand 21 | 0.018 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.018 | ||
| TCF21 | transcription factor 21 | 0.018 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.017 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.017 | ||
| C1S | complement component 1, s subcomponent | 0.017 | ||
| NKX3-2 | NK3 homeobox 2 | 0.017 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.017 | ||
| GABARAPL2 | GABA(A) receptor-associated protein-like 2 | 0.017 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.017 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.017 | ||
| CD1B | CD1b molecule | 0.017 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.017 | ||
| CBX8 | chromobox homolog 8 | 0.017 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.017 | ||
| TNS1 | tensin 1 | 0.017 | ||
| GAS1 | growth arrest-specific 1 | 0.017 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.017 | ||
| CETP | cholesteryl ester transfer protein, plasma | 0.016 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.016 | ||
| WNT9B | wingless-type MMTV integration site family, member 9B | 0.016 | Human | |
| GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.016 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.016 | ||
| MADCAM1 | mucosal vascular addressin cell adhesion molecule 1 | 0.016 | ||
| EIF2D | eukaryotic translation initiation factor 2D | 0.016 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.016 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.016 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.016 | ||
| DLX4 | distal-less homeobox 4 | 0.016 | ||
| NPPC | natriuretic peptide C | 0.016 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.016 | Human | |
| SNCAIP | synuclein, alpha interacting protein | 0.016 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.016 | Human | |
| PRKCD | protein kinase C, delta | 0.016 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.016 | ||
| IL21 | interleukin 21 | 0.015 | ||
| CD160 | CD160 molecule | 0.015 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.015 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.015 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.015 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.015 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.015 | ||
| BMP10 | bone morphogenetic protein 10 | 0.015 | Human | |
| AQP5 | aquaporin 5 | 0.015 | ||
| LHX3 | LIM homeobox 3 | 0.015 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.015 | ||
| BNC1 | basonuclin 1 | 0.015 | ||
| PLEK | pleckstrin | 0.015 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.015 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.015 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.015 | ||
| GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 | 0.015 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.015 | ||
| CCDC48 | coiled-coil domain containing 48 | 0.015 | ||
| SELPLG | selectin P ligand | 0.015 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.015 | ||
| GPC3 | glypican 3 | 0.015 | ||
| KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | 0.015 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.015 | ||
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.015 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.015 | ||
| CHRND | cholinergic receptor, nicotinic, delta | 0.015 | ||
| COL19A1 | collagen, type XIX, alpha 1 | 0.014 | ||
| RING1 | ring finger protein 1 | 0.014 | ||
| FGF17 | fibroblast growth factor 17 | 0.014 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.014 | ||
| PHOX2A | paired-like homeobox 2a | 0.014 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.014 | ||
| NEUROG1 | neurogenin 1 | 0.014 | Human | |
| POSTN | periostin, osteoblast specific factor | 0.014 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.014 | ||
| TCF12 | transcription factor 12 | 0.014 | ||
| VSX1 | visual system homeobox 1 | 0.014 | ||
| HOXC8 | homeobox C8 | 0.014 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.014 | ||
| GATA3 | GATA binding protein 3 | 0.014 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.014 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.014 | ||
| VMP1 | vacuole membrane protein 1 | 0.014 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.014 | ||
| DIO3 | deiodinase, iodothyronine, type III | 0.014 | ||
| EDN1 | endothelin 1 | 0.014 | ||
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.014 | ||
| TM7SF4 | transmembrane 7 superfamily member 4 | 0.014 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.014 | ||
| IL5RA | interleukin 5 receptor, alpha | 0.013 | ||
| THY1 | Thy-1 cell surface antigen | 0.013 | ||
| NKX3-1 | NK3 homeobox 1 | 0.013 | ||
| APOBEC3G | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G | 0.013 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.013 | ||
| ITIH5 | inter-alpha (globulin) inhibitor H5 | 0.013 | ||
| FBLN1 | fibulin 1 | 0.013 | ||
| LAMA2 | laminin, alpha 2 | 0.013 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.013 | ||
| BHLHE22 | basic helix-loop-helix family, member e22 | 0.013 | ||
| SHOX2 | short stature homeobox 2 | 0.013 | ||
| SFTPB | surfactant protein B | 0.013 | ||
| FMO1 | flavin containing monooxygenase 1 | 0.013 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.013 | ||
| CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 | 0.013 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.013 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.013 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.013 | ||
| FRZB | frizzled-related protein | 0.013 | ||
| HGFAC | HGF activator | 0.013 | ||
| ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0.013 | ||
| RUNX3 | runt-related transcription factor 3 | 0.013 | ||
| OAF | OAF homolog (Drosophila) | 0.013 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.013 | ||
| TG | thyroglobulin | 0.013 | ||
| DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 0.013 | ||
| ALPL | alkaline phosphatase, liver/bone/kidney | 0.013 | ||
| PRPH | peripherin | 0.013 | ||
| ACVR2B | activin A receptor, type IIB | 0.013 | ||
| XCR1 | chemokine (C motif) receptor 1 | 0.013 | Human | |
| HTT | huntingtin | 0.013 | ||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.012 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.012 | ||
| LMO1 | LIM domain only 1 (rhombotin 1) | 0.012 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.012 | ||
| TBR1 | T-box, brain, 1 | 0.012 | ||
| EPHA3 | EPH receptor A3 | 0.012 | ||
| LBX1 | ladybird homeobox 1 | 0.012 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.012 | ||
| EMCN | endomucin | 0.012 | ||
| SHH | sonic hedgehog | 0.012 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.012 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.012 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.012 | ||
| COL9A2 | collagen, type IX, alpha 2 | 0.012 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.012 | ||
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.012 | Rat | |
| FHL1 | four and a half LIM domains 1 | 0.012 | ||
| FOXD3 | forkhead box D3 | 0.012 | ||
| MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.012 | ||
| EVI2A | ecotropic viral integration site 2A | 0.012 | ||
| EDNRB | endothelin receptor type B | 0.012 | ||
| PIGP | phosphatidylinositol glycan anchor biosynthesis, class P | 0.012 | ||
| GRP | gastrin-releasing peptide | 0.012 | ||
| FAM123C | family with sequence similarity 123C | 0.012 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.012 | ||
| PAX3 | paired box 3 | 0.012 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.012 | ||
| MFAP2 | microfibrillar-associated protein 2 | 0.012 | ||
| GSC2 | goosecoid homeobox 2 | 0.012 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| BMP6 | bone morphogenetic protein 6 | 0.012 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.012 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.012 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.012 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.012 | Human | |
| KRT76 | keratin 76 | 0.012 | ||
| STMN2 | stathmin-like 2 | 0.012 | ||
| SIGLEC6 | sialic acid binding Ig-like lectin 6 | 0.012 | ||
| TLX3 | T-cell leukemia homeobox 3 | 0.012 | ||
| DRD4 | dopamine receptor D4 | 0.012 | ||
| EPYC | epiphycan | 0.012 | ||
| UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 0.012 | ||
| NME3 | non-metastatic cells 3, protein expressed in | 0.012 | ||
| ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | 0.011 | ||
| MEX3C | mex-3 homolog C (C. elegans) | 0.011 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.011 | ||
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.011 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.011 | ||
| CLU | clusterin | 0.011 | ||
| HOXB8 | homeobox B8 | 0.011 | ||
| NCR3 | natural cytotoxicity triggering receptor 3 | 0.011 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.011 | ||
| PHOX2B | paired-like homeobox 2b | 0.011 | ||
| ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | 0.011 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.011 | Human | |
| HOXD3 | homeobox D3 | 0.011 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.011 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.011 | ||
| NODAL | nodal homolog (mouse) | 0.011 | Human | |
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.011 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.011 | ||
| GJA3 | gap junction protein, alpha 3, 46kDa | 0.011 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.011 | ||
| GDF6 | growth differentiation factor 6 | 0.011 | Human | |
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.011 | ||
| MATN2 | matrilin 2 | 0.011 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.011 | Human | |
| NEXN | nexilin (F actin binding protein) | 0.011 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.011 | ||
| STAB2 | stabilin 2 | 0.011 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.011 | ||
| VTN | vitronectin | 0.011 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.011 | Human | |
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.011 | Human | |
| PITPNM3 | PITPNM family member 3 | 0.011 | ||
| PTHLH | parathyroid hormone-like hormone | 0.011 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.011 | ||
| FEV | FEV (ETS oncogene family) | 0.011 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.011 | ||
| CCBP2 | chemokine binding protein 2 | 0.011 | Human | |
| PRDM14 | PR domain containing 14 | 0.011 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.011 | ||
| OTP | orthopedia homeobox | 0.011 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.011 | ||
| S100A12 | S100 calcium binding protein A12 | 0.011 | ||
| NEUROG3 | neurogenin 3 | 0.011 | Human | |
| LRRN2 | leucine rich repeat neuronal 2 | 0.011 | ||
| FOXF1 | forkhead box F1 | 0.011 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.011 | ||
| DEC1 | deleted in esophageal cancer 1 | 0.011 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.011 | ||
| EYA2 | eyes absent homolog 2 (Drosophila) | 0.011 | ||
| FOXL1 | forkhead box L1 | 0.011 | ||
| HIC2 | hypermethylated in cancer 2 | 0.011 | ||
| HEMGN | hemogen | 0.011 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.011 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.011 | ||
| EMP1 | epithelial membrane protein 1 | 0.011 | ||
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.011 | ||
| F10 | coagulation factor X | 0.011 | ||
| ITGB8 | integrin, beta 8 | 0.011 | ||
| AVPR1A | arginine vasopressin receptor 1A | 0.010 | ||
| OSMR | oncostatin M receptor | 0.010 | ||
| FLNB | filamin B, beta | 0.010 | ||
| HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E | 0.010 | ||
| PRNP | prion protein | 0.010 | ||
| C19orf6 | chromosome 19 open reading frame 6 | 0.010 | ||
| CILP | cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | 0.010 | ||
| ANGPT4 | angiopoietin 4 | 0.010 | ||
| PRDM6 | PR domain containing 6 | 0.010 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.010 | ||
| TLX2 | T-cell leukemia homeobox 2 | 0.010 | ||
| OCLN | occludin | 0.010 | ||
| PRDM13 | PR domain containing 13 | 0.010 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.010 | ||
| ACVR1B | activin A receptor, type IB | 0.010 | Human | |
| APOC1 | apolipoprotein C-I | 0.010 | ||
| IL1RAPL2 | interleukin 1 receptor accessory protein-like 2 | 0.010 | ||
| BHLHE23 | basic helix-loop-helix family, member e23 | 0.010 | ||
| HOXD11 | homeobox D11 | 0.010 | ||
| HOXD10 | homeobox D10 | 0.010 | ||
| CRELD2 | cysteine-rich with EGF-like domains 2 | 0.010 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.010 | ||
| DFNA5 | deafness, autosomal dominant 5 | 0.010 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.010 | ||
| PAM | peptidylglycine alpha-amidating monooxygenase | 0.010 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.010 | ||
| SOX17 | SRY (sex determining region Y)-box 17 | 0.010 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.010 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.010 | ||
| STRA6 | stimulated by retinoic acid gene 6 homolog (mouse) | 0.010 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.010 | ||
| CTSK | cathepsin K | 0.010 | ||
| UNC5B | unc-5 homolog B (C. elegans) | 0.010 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.010 | ||
| KREMEN2 | kringle containing transmembrane protein 2 | 0.010 | ||
| HDC | histidine decarboxylase | 0.010 | ||
| OMD | osteomodulin | 0.010 | ||
| GLYAT | glycine-N-acyltransferase | 0.010 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.010 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.010 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.010 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.010 | ||
| RXRA | retinoid X receptor, alpha | 0.010 | ||
| DUOX1 | dual oxidase 1 | 0.010 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.010 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.010 |